AU6381000A - Methods and compositions for alleviating stuttering - Google Patents

Methods and compositions for alleviating stuttering

Info

Publication number
AU6381000A
AU6381000A AU63810/00A AU6381000A AU6381000A AU 6381000 A AU6381000 A AU 6381000A AU 63810/00 A AU63810/00 A AU 63810/00A AU 6381000 A AU6381000 A AU 6381000A AU 6381000 A AU6381000 A AU 6381000A
Authority
AU
Australia
Prior art keywords
compositions
methods
stuttering
alleviating
alleviating stuttering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63810/00A
Inventor
Kay Jorgenson D'orlando
John J. Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indevus Pharmaceuticals Inc
Original Assignee
Interneuron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interneuron Pharmaceuticals Inc filed Critical Interneuron Pharmaceuticals Inc
Publication of AU6381000A publication Critical patent/AU6381000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU63810/00A 1999-07-29 2000-07-27 Methods and compositions for alleviating stuttering Abandoned AU6381000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36269199A 1999-07-29 1999-07-29
US09362691 1999-07-29
PCT/US2000/020402 WO2001008670A2 (en) 1999-07-29 2000-07-27 Methods and compositions for alleviating stuttering

Publications (1)

Publication Number Publication Date
AU6381000A true AU6381000A (en) 2001-02-19

Family

ID=23427132

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63810/00A Abandoned AU6381000A (en) 1999-07-29 2000-07-27 Methods and compositions for alleviating stuttering

Country Status (2)

Country Link
AU (1) AU6381000A (en)
WO (1) WO2001008670A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783516B2 (en) 2001-04-30 2005-11-03 Warner-Lambert Company Methods, kits and compositions for using pyrrole derivatives
JP4994570B2 (en) 2001-07-04 2012-08-08 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド Stomach retention control drug delivery system
US20120322781A1 (en) 2010-01-14 2012-12-20 Umecrine Mood Ab Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
EP2675822A4 (en) 2011-02-15 2014-07-30 Socpra Sciences Et Génie S E C Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria
EP3030081B1 (en) * 2013-08-05 2017-08-02 Syngenta Participations AG Pyrazolyl pyrrolinones and their use as herbicides
BR112019015362A2 (en) 2017-02-10 2020-10-20 Asarina Pharma Ab 3-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (en) * 1986-12-02 1989-02-24 Rhone Poulenc Sante NOVEL ISOINDOLINONE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2015336A1 (en) * 1989-05-19 1990-11-19 F. Hoffmann-La Roche Ag Imidazodiazepines for the treatment of neurological symptoms
EP0852496A4 (en) * 1995-09-29 1998-11-11 Lilly Co Eli Method for treating a tic disorder
JP4562911B2 (en) * 1998-01-13 2010-10-13 シンクロニュ−ロン，エルエルシ− Method for treating tardive dyskinesia and other movement disorders

Also Published As

Publication number Publication date
WO2001008670A3 (en) 2002-08-29
WO2001008670A2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
AU7960200A (en) Sealing composition and sealing method
AU2001261566A1 (en) Well service composition and method
AU4133701A (en) Methods and compositions for peptide synthesis
AU3901100A (en) Method and composition for waterproofing
AU2002361623A1 (en) Methods and compositions for chromatography
AU5326100A (en) Pharmaceutical compositions and methods for use
AU4318000A (en) Agarobiose-containing composition
AU2349399A (en) R-lansoprazole compositions and methods
AU6056500A (en) Process and composition for temporarily suppressing pain
AU7474100A (en) Methods and compositions for reducing immune response
AU2681500A (en) Rapidly-soluble compositions
AU6381000A (en) Methods and compositions for alleviating stuttering
AU5085300A (en) Compositions
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU1597001A (en) Compositions and methods for modifying an immune response against tropomyosin
AU6720100A (en) Depigmenting compositions
AU2001253481A1 (en) Methods and compositions for eleciting an immune response
AU4809000A (en) Method and composition for waterproofing
AU6310600A (en) Composition
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU4328700A (en) Pseudomycin antifungal compositions and methods for their use
AU5243899A (en) Methods and compositions for using moclobemide
AU1477601A (en) Genetic compositions and methods
AU5931300A (en) Ringene compositions and methods for use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase